Mv Capital Management, Inc. Novo Cure LTD Transaction History
Mv Capital Management, Inc.
- $920 Million
- Q3 2024
A detailed history of Mv Capital Management, Inc. transactions in Novo Cure LTD stock. As of the latest transaction made, Mv Capital Management, Inc. holds 14 shares of NVCR stock, worth $449. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14
Previous 14
-0.0%
Holding current value
$449
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NVCR
# of Institutions
263Shares Held
77MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$389 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$380 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$254 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$138 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$97.3 Million12.67% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $3.37B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...